Becton, Dickinson and Company Officer Departure

2026-04-09SEC Filing 8-K (0001628280-26-024472)

Richard E. Byrd, Executive Vice President and President of the Interventional segment, has announced his intention to retire from Becton, Dickinson and Company (BD). Mr. Byrd, who has been with BD for nearly 25 years, will remain in his role through June 2026. During his tenure, he held significant leadership positions, including worldwide president of Medication Delivery Solutions and worldwide president of Preanalytical Systems. BD has stated that a successor will be named before his retirement. The company expressed gratitude for his contributions, highlighting his role in strengthening the company's portfolio, operational rigor, and leadership in healthcare. Mr. Byrd cited the people of BD as his greatest inspiration and expressed confidence in the company's future.

Ticker mentioned:BDX